SUTENT® (sunitinib malate) Slide Kit
Necitumumab imc 11 f8 ottobre 2010
Necitumumab imc 11 f8 ott 2010
1 XENOX J. CASSIDY, G.A. BJARNASON, T. HICKISH, C. TOPHAM, M. PROVENCIO, G. BODOKY, L. LANDHERR, P. KORALEWSKI, G. LOPEZ-VIVANCO, G. SAID BEATSON ONCOLOGY.
Study JMDB - A Randomised Phase III Trial of Cisplatin + Pemetrexed vs. Cisplatin + Gemcitabine in Locally Advanced or Metastatic Non-small Cell Lung Cancer.
A Phase III, Randomized, Double-Blind, Placebo-Controlled Registration Trial to Evaluate the Efficacy and Safety of Placebo + Trastuzumab + Docetaxel vs.
S. Pignata 1 , G. Scambia 2 , A. Savarese 3 , R. Sorio 4 , E. Breda 5 ,
AVADO
AAP OSA Guidelines.doc
XENOX
1 ODAC September 13 th, 2005 Tarceva ® (erlotinib) Adrian Senderowicz, M.D. DDODP, CDER FDA.
Eric Van Cutsem*
